An open-label prospective study of restless legs patients switched to ropinirole from pramipexole to help determine the equipotent dose.
Phase of Trial: Phase IV
Latest Information Update: 17 Aug 2016
At a glance
- Drugs Ropinirole (Primary) ; Pramipexole
- Indications Restless legs syndrome
- Focus Therapeutic Use
- Acronyms SWITCH
- 11 May 2011 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 11 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Nov 2006 New trial record.